117 related articles for article (PubMed ID: 5218078)
1. The management of chronic myeloproliferative disorders.
Krakoff IH
Med Clin North Am; 1966 May; 50(3):803-17. PubMed ID: 5218078
[No Abstract] [Full Text] [Related]
2. Secondary gout associated with chronic myeloproliferative disorders.
Yu T; Weinreb N; Wittman R; Wasserman LR
Semin Arthritis Rheum; 1976 Feb; 5(3):247-56. PubMed ID: 1062009
[No Abstract] [Full Text] [Related]
3. Treatment of myeloproliferative diseases.
Sellei C
Ther Hung; 1966; 14(4):135-6. PubMed ID: 5228101
[No Abstract] [Full Text] [Related]
4. When to use chemotherapy for chronic hematopoietic neoplasms.
Yu KP; Krakoff IH
Postgrad Med; 1968 May; 43(5):176-83. PubMed ID: 5239464
[No Abstract] [Full Text] [Related]
5. Secondary gout associated with myeloproliferative diseases.
Yü TF
Arthritis Rheum; 1965 Oct; 8(5):765-71. PubMed ID: 5216775
[No Abstract] [Full Text] [Related]
6. [Chronic myeloproliferative diseases].
Sréter L
Orv Hetil; 1998 Jul; 139(30):1779-83. PubMed ID: 9718944
[TBL] [Abstract][Full Text] [Related]
7. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M
Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954
[No Abstract] [Full Text] [Related]
8. [The treatment of myeloproliferative syndromes].
Maurice P
Schweiz Med Wochenschr; 1975 Oct; 105(40):1269-74. PubMed ID: 1061995
[TBL] [Abstract][Full Text] [Related]
9. [On the effect of a new cytostatic drug in chronic myeloses and polycythemias].
Böhnel J; Stacher A
Wien Med Wochenschr; 1968 Sep; 118(37):721-3. PubMed ID: 5248360
[No Abstract] [Full Text] [Related]
10. Myeloproliferative diseases.
Silverstein MN
Postgrad Med; 1977 Feb; 61(2):206-10. PubMed ID: 556856
[TBL] [Abstract][Full Text] [Related]
11. [Familial myeloproliferative syndromes. Study of 6 families and review of literature].
Kaufman S; Brière J; Bernard J
Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):1-15. PubMed ID: 353725
[TBL] [Abstract][Full Text] [Related]
12. [The treatment of myelo-proliferative syndromes].
Bousser J
Sem Ther; 1965; 41(6):349-52. PubMed ID: 5234604
[No Abstract] [Full Text] [Related]
13. Polycythemia vera, myeloid metaplasia with terminal myelogenous leukemia.
LITWINS J; GREENWALD L; GREENWALD HP
Bulletin NY Med Coll; 1955; 18():38-45. PubMed ID: 13329577
[No Abstract] [Full Text] [Related]
14. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
15. [Relation of polycythemia vera (Vaquez' disease) to myelosclerosis and leukosis. Polycythemia vera and so-called myeloproliferative states].
MAYER G; MAYER S; WAITZ R
Rev Prat; 1962 Sep; 12():2399-410. PubMed ID: 13934120
[No Abstract] [Full Text] [Related]
16. MYELOPROLIFERATIVE SYNDROME; EVALUATION OF MYELOSCLEROSIS AND CHRONIC MYELOGENOUS LEUKEMIA TO POLYCYTHEMIA VERA.
LOPAS H; JOSEPHSON AM
Arch Intern Med; 1964 Dec; 114():754-9. PubMed ID: 14211587
[No Abstract] [Full Text] [Related]
17. Uric acid in human plasma. IV. Investigations on the interactions between urate and the macromolecular fraction in plasma from healthy individuals and patients with diseases associated with hyperuricemia.
Alvsaker JO
Scand J Clin Lab Invest; 1965; 17(5):476-82. PubMed ID: 5214786
[No Abstract] [Full Text] [Related]
18. [THE MYELOPROLIFERATIVE SYNDROME FROM THE VIEWPOINT OF CLINICAL HEMATOLOGISTS].
KUNZ G
Z Gesamte Inn Med; 1964 Dec; 19():SUPPL:194-7. PubMed ID: 14235899
[No Abstract] [Full Text] [Related]
19. Platelet defects in the myeloproliferative disorders.
Inceman S; Tangün Y
Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
[No Abstract] [Full Text] [Related]
20. Chronic myeloproliferative neoplasms in the elderly.
Maffioli M; Orlandi E; Passamonti F
Eur J Intern Med; 2018 Dec; 58():33-42. PubMed ID: 29793825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
